FDA 483 - Sionc Pharmaceuticals Private Limited - August 02, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Sync Pharmaceuticals Pvt. Ltd., an API manufacturer in Parawada, India, revealed significant deficiencies in their quality control unit and cleaning process validation. Inspectors found inadequate controls over electronic data, including unpassworded hard drives and shared computer logins, raising concerns about data integrity. Additionally, the firm failed to adequately document cleaning process validation, with inconsistent surface area calculations lacking justification.
ID · 46000116-5a9f-48e8-ae7b-f7ccd90f8410